Navigation Links
OxiMax NPB-40 Handheld Pulse Oximeter

ProductsOxiMax NPB-40 Handheld Pulse Oximeter
Company Nellcor
Item OxiMax NPB-40 Handheld Pulse Oximeter
Features 
  • Nellcor's advanced signal processing technology delivers reliable operation even in challenging monitoring conditions.
  • Compatible with the complete line of single-patient-use, reusable and specialty OxiMax sensors.
  • Conveniently small and lightweight.
  • Ergonomic shape and simple keypad make it easy to operate.
  • Audible and visible alarms.
  • Bright blue, backlit display is easy to see in any lighting conditions.
  • Long battery life: 19 or 40 hours depending on battery type.
  • Optional portable Citizen printer to facilitate patient documentation.
  • Optional protective cases available in four color choices.
    • Description Nellcor's most popular handheld oximeter has been converted to the Nellcor OxiMax Pulse Oximetry platform and is now compatible with the entire line of innovative OxiMax sensors, including the MAX-FAST Forehead Sensor and SoftCare Nonadhesive Sensors. The redesigned OxiMax NPB-40 Handheld Pulse Oximeter also incorporates Nellcor's latest advanced signal processing technology, which stands up to challenges such as patient motion, low perfusion or electrical interference that can hamper most other handhelds. As a result, the OxiMax NPB-40 Handheld Pulse Oximeter can more effectively monitor a broader range of patients.
    Info Nellcor
    Customer Service: (800) 635-5267

    Related medicine products :

    1. OxiMax® N-595 Pulse Oximeter
    2. OxiMax® N-550 Pulse Oximeter
    3. OxiMax® NPB-75 Handheld Capnograph/Pulse Oximeter
    4. NPB-40 Handheld Pulse Oximeter
    5. Handheld STG
    6. Pulsair EasyEye Handheld Non-Contact Tonometer
    7. pH 200 series, F 295 Handheld, Water-Proof pH/Temp/mV/ISE Meter
    8. pH 200 series, F 265 Handheld, Water-Proof pH/Temp/mV Meter With Electrode
    9. pH 200 series, F 255 Handheld, Water-Proof pH/Temp/mV Meter
    10. pH 200 series, F 260 Handheld, pH/Temp/mV Meter
    11. pH 200 series, F 250 Handheld, pH/Temp/mV Meter
    ...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
    ...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
    ...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
    ...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
    Medicine Products:
    (Date:11/21/2008)...l/ -- Heska Corporation,(Nasdaq: HSKA ) today a...f,Security Analysts, 12th Annual Biotech and Spec...77 Avenue of the Americas, 2nd Floor in New York, ...5 a.m. Eastern Time (7:35 a.m.,Mountain Time) and...eks,following the presentation through a link und...
    (Date:11/21/2008)... Lennox-Gastaut syndrome , , FRIDAY, Nov...(rufinamide) has been approved as a supplementary ...nox-Gastaut syndrome, the U.S. Food and Drug Admin...based on results of a four-month clinical trial th...ients who took a placebo, those who took the drug ...
    (Date:11/21/2008)...Center.com, the premier site,for online nursing c... been,updated to improve the interactive experien...ippincott Williams & Wilkins (LWW), NursingCen...nuing education activities and free,access to 11,...rnals.,Lippincott Williams & Wilkins is a par...
    (Date:11/21/2008)...stCall/ -- Today, prescription drugs are the first...rcent of patients suffering chronic conditions. T...ondition account for 96 percent of all prescriptio...s. A proprietary new pharmacy model developed ove...E: MHS ) significantly reduces critical gaps in ...
    Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
    ... and dental hygienists as lifesavers, but Dr. Gwen...ant professor of dental// hygiene at New York City...to routinely conduct periodontal evaluations and o...s well as how to recognize the clinical signs of s...
    ... cells from the lungs of transplant patients demon...ells //reside in adult organs and are not derived ...hat the cells may be able to help with the rejecti...kinds of lung disease. The study by University of...
    ...and the Medicines for Malaria Venture plan to fund...nited Arab Emirates (UAE). The center will focus o...Gulf News reports. Gates Foundation and MMV repre...ials from the UAE Ministry of Health to discuss th...
    ...e parents of Canada’s conjoined twins and to the p...have confirmed //after days of several tests that ...ined twins, known by the names Krista and Tatiana ...eads joined. The twins, who are four months of age...
    Other Medicine News:Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 2Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 3Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 4Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 3
    (Date:11/13/2008)...ds Statins Cut Risk of Heart Attacks, Deaths, RES...ovascular Disease,is the leading cause of death am...eds of millions of dollars and causing untold suff...atal disease - even among those who,weren,t though...ions of people could cut their risk of a,heart att...
    (Date:11/12/2008)...mes D. Watson, Marilyn & James Simons and,Sherry L...., Nov. 12 J. Craig Ven...Venter Institute (JCVI), was,awarded the Double He...) on,November 6th at a gala event in New York City...ng with Dr. James D.,Watson for making each of the...
    (Date:11/12/2008)...Provides Reversible, High-level Platelet ...NEW ORLEANS and SOUTH SAN FRANCISCO, Calif., Nov. ...harmaceutical company developing innovative,drugs ...r and inflammatory,diseases, and cancer, today ann...8, the Company,s novel anti-platelet drug that dir...
    (Date:11/12/2008)... its kind shows no clinically meaningful, differen... nearsightedness, JACKSONVILLE, Fla., Nov. 12 /PR...t in clinically significant acceleration in the de...not cause relevant increases in axial,length or co...the,three-year study, the largest randomized trial...
    Breaking Medicine Technology:Seniors Can Be Heartened by New Study on Statins 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 2Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 3Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas April 14 16 2008 16386 1Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas April 14 16 2008 16386 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 1MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 2MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 3MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
    ...s intramuscular injection of peramivir for eight,d...s infection and,inhibited virus replication, suppo...ring a pandemic, MEMPHIS, Tenn., May 01, 2007 /PRN...r might offer humans significant protection,during...ording to,results of mouse studies conducted by in...
    ...ND, Sweden--(BUSINESS WIRE)--May 1, 2007 - Teva,Ph... today,announced that data from a 36-week, randomi...udy demonstrated that an oral 0.6 mg,dose of laqui...esonance imaging (MRI) disease activity by 38 perc...dition, there was a favorable,trend towards reduci...
    Other Medicine Technology:Peramivir Protects Mice From Lethal H5N1 Infection 2Peramivir Protects Mice From Lethal H5N1 Infection 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6